Articles
Effect of Vehicle Amphiphilicity on the Dissolution and Bioavailability of a Poorly Water-Soluble Drug from Solid Dispersions

https://doi.org/10.1002/jps.2600770512Get rights and content

Abstract

Solid dispersions of a poorly water-soluble drug [REV 5901; α-pentyl-3-(2-quinolinylmethoxy)benzenemethanol; 1] in an amphiphilic vehicle [Gelucire 44/14; 2] and in polyethylene glycol (PEG) 1000, PEG 1450, and PEG 8000 were prepared. The vehicle 2 was a mixture of hydrogenated fatty acid esters with a mp of 44°C, and had a HLB value of 14. Compound 1 was dissolved or dispersed in molten vehicles at elevated temperatures. The pulverization and compression of solid dispersions were avoided by encapsulating the hot solutions directly into hard gelatin capsules. At room temperature, the dispersions solidified forming plugs inside the capsules. On storage, >180 mg of 1 remained dissolved per gram of vehicle, while the excess drug formed fine crystals (<20 μm). When mixed with water, the dissolved drug separated as a metastable liquid. Due to the surfactant property of 2, the oily form of 1 that separated from this vehicle formed an emulsified system with a globular size of <1 μm, while >80% of 1 that separated from the other three formulations coalesced to form large oily masses. As a result of the large difference in surface area, the dissolution rate of 1 in simulated gastric fluid from capsules containing 2 was much higher than that of a PEG-based formulation. The bioavailability (AUC) of 1 in dogs from capsules containing 2 was also higher than that from PEG 1000-based capsules.

References and Notes (20)

  • ChiouW.L. et al.

    J. Pharm. Sci.

    (1971)
  • KaurR. et al.

    J. Pharm. Sci.

    (1980)
  • SerajuddinA.T.M. et al.

    J. Pharm. Sci.

    (1986)
  • SekiguchiK. et al.

    Chem. Pharm. Bull.

    (1961)
  • StephensonD.

    Patent 942 743

    (1963)
  • CorriganO.I.

    Drug. Dev. Ind. Pharm.

    (1985)
  • McGinityJ.W.

    Pharm. Tech.

    (1978)
  • FordJ.L. et al.

    J. Pharm. Pharmacol.

    (1977)
  • FordJ.L. et al.

    . Pharm. Acta Helv.

    (1980)
  • McGinityJ.W. et al.

    J. Pharm. Sci.

    (1984)
There are more references available in the full text version of this article.

Cited by (174)

  • Aqueous Dissolution and Dispersion Behavior of Polyvinylpyrrolidone Vinyl Acetate-based Amorphous Solid Dispersion of Ritonavir Prepared by Hot-Melt Extrusion with and without Added Surfactants

    2021, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    One major reason for incomplete drug release from ASD is that once the water-soluble carrier starts dissolving from near the surface, the liberated water-insoluble drug coats the surface of particles or dosage units, preventing further dissolution of drug from the interior.57 Such a surface coating of ASDs by the water-insoluble drug may be avoided if a surface active carrier is used58 or a surfactant is added to the formulation as the surfactant would facilitate dispersion of the liberated drug in dissolution media.63 It is apparent from the results of dispersion testing presented in Fig. 5 that the possible surface coating by relatively water-insoluble ritonavir might not be a major issue in the release of drugs containing PVPVA as the polymeric carrier, since 80–90% of drug either dissolved or dispersed as fine particles in the aqueous phase even when no additional surfactant was present in the formulation.

  • Influence of formulation variables on miconazole nitrate–loaded lipid based nanocarrier for topical delivery

    2020, Colloids and Surfaces B: Biointerfaces
    Citation Excerpt :

    Moreover, F4 and F5 contain Cremophor® RH 40, which has higher solubilizing capacity for lipophilic MN because of its high molecular weight giving particles with a smaller size than that of Tweens containing formulae (F16, F17, and F18), with a lower solubilizing capacity of lipophilic MN drug, it could be also interpreted by the partitioning drug effects between the lipid -aqueous phase throughout particle production [80], and hence improving higher dissolution rate result in higher drug release efficiency. Furthermore, formula F18 showed first faster release than other formulae this could be attributed to high HLB of Gelucire® 44/14, which may accelerate the release of the drug from the lipid matrices [61,81–83]. Interpretation of drug release data was performed using mathematical models.

  • Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release

    2019, Journal of Pharmaceutical Sciences
    Citation Excerpt :

    Lesser hydrophilic P407 and TPGS with the low HLB values of 22 and 13, respectively, provided progressively higher dissolution rates. Serajuddin et al.64,65 reported that water-insoluble liquid or amorphous layers of poorly water-soluble drugs are formed on the surface of solid dispersions during dissolution, thus blocking further release from inside the ASD pellets or particles, and the presence of surfactants in ASDs prevents the formation of such layers by emulsifying or suspending the liberating drug. It is apparent in the present investigation that the lower HLB value of surfactants favors more efficient removal of drug from the dissolving surface.

View all citing articles on Scopus
View full text